Gatifloxacin and dysglycemia in older adults [5]

New England Journal of Medicine

Volumn 354, Issue 25, 2006, Pages 2725-2726

  Yadav, Vijay ^a   Deopujari, Kuldeep ^a  

^a GANDHI MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GATIFLOXACIN; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

DRUG EFFICACY; DYSGLYCEMIA; HUMAN; HYPOGLYCEMIA; LETTER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; TUBERCULOSIS; CHEMICALLY INDUCED DISORDER; HYPERGLYCEMIA; MORTALITY; NOTE;

ANTI-BACTERIAL AGENTS; FLUOROQUINOLONES; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MORTALITY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 33745239748     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc066207     Document Type: Letter

References (3)

1. Sriram D, Aubry A, Yogeeswari P, Fisher LM. Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase. Bioorg Med Chem Lett 2006;16:2982-5.
2. Paramasivan CN, Sulochana S, Kubendiran G, Venkatesan P, Mitchison DA. Bactericidal action of gatifloxacin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2005;49:627-31.
3. Sulochana S, Rahman F, Paramasivan CN. In vitro activity of fluoroquinolones against Mycobacterium tuberculosis. J Chemother 2005;17:169-73.